黑質(zhì)區(qū)微注射魚藤酮對(duì)大鼠紋狀體和丘腦腹外側(cè)核神經(jīng)元電活動(dòng)的影響
[Abstract]:As a widely used pesticide, rotenone (Rotenone) can induce neurotoxicity of Parkinson's disease (Parkinson's Disease,PD). However, previous studies have mostly used peripheral exposure methods to observe specific neuropathological and behavioral changes in the brain. However, the mechanism of electrical activity of basal ganglion and motor thalamic neurons involved in PD motor dysfunction caused by pathological changes is seldom reported. In this study, SD rats were studied to detect whether rotenone microinjection induced PD motility disorder and specific pathological changes of substantia nigra DA neurons. Furthermore, the effect on the electrical activity of striatum and ventrolateral thalamus neurons was investigated, and the possible neural mechanism of motor disorder was analyzed. The main results were as follows: after exposure to 1.2 渭 g rotenone 3 渭 g and 5 渭 g rotenone for 21 days, the movement delay on vertical grid was significantly prolonged in rats compared with control group and self exposure. And it was prolonged with the increase of rotenone exposure dose. The number of falls from the inclined plate increased significantly in rats. In the open test, the number of holes and the time to stand upright in rotenone exposure group were significantly decreased compared with those before exposure, and there was a dose-effect relationship between rotenone and rotenone exposure group. Tremors induced by rotenone exposure were observed in half of the animals. 2. The results of immunohistochemistry showed that the number of tyrosine hydroxylase positive neurons in substantia nigra was significantly decreased after rotenone exposure, and the loss of neurons increased with the increase of exposure dose. The residual TH positive neurons atrophy, the neurites decreased or disappeared, showing progressive degeneration. 3. The spontaneous discharge pattern of striatum neurons was changed after rotenone exposure, the mixed cluster firing neurons increased significantly, the monopulse and irregular firing neurons decreased significantly, and the frequency of spontaneous discharge increased significantly. Compared with the control group, the striatal neurons showed an excitatory tendency to stimulate the motor cortex after rotenone exposure, and the response delay was decreased. 4. After exposure to rotenone, the neurons in the ventrolateral thalamic nucleus (VL) with explosive spontaneous discharges increased significantly, the frequency of spontaneous discharges decreased generally, and the peak of the discharge spectrum gathered to the low frequency region. Rotenone exposure resulted in a relative decrease in the number of VL neurons excited by motor cortex stimuli, while the delay in response to the stimuli was significantly increased compared with the control group. These results suggest that the direct microinjection of rotenone in the substantia nigra can induce the symptoms of typical Parkinson's disease such as motor retardation muscle stiffness and tremor in rats. It also leads to progressive loss of dopaminergic neurons in the substantia nigra compact, a typical pathological change in Parkinson's disease. Rotenone exposure resulted in increased spontaneous activity of striatum neurons and an increase in excitability of motor cortex stimulation, suggesting that increased activity of striatum neurons might be associated with PD specific motor dysfunction. After rotenone exposure, the burst spontaneous discharges of neurons in the ventrolateral thalamic nucleus increased, suggesting that the electrical activity of neurons in the ventrolateral thalamic nucleus might be closely related to the behavioral changes such as PD motility retardation and tremor. Our work provides a reference for the establishment of PD animal model by central direct exposure to rotenone, and provides a theoretical basis for the surgical treatment of PD in striatum and ventrolateral thalamus. It also provides evidence for the mechanism of striatum and ventrolateral nucleus of thalamus involved in motor regulation.
【學(xué)位授予單位】:華東師范大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2007
【分類號(hào)】:R363
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 王紹梁,陳來照,薛乃照,劉躍亭,李守緘,朱宏偉,李勇杰;蒼白球腹后部切開術(shù)治療帕金森病靶點(diǎn)定位規(guī)律探討[J];中華神經(jīng)醫(yī)學(xué)雜志;2004年03期
2 潘鶴鳴;;CT結(jié)合術(shù)中微電極導(dǎo)向及電刺激定向毀損治療帕金森病[J];海南醫(yī)學(xué);2006年09期
3 劉建峰,郭常利,周劍云,宋劍,王爭(zhēng);CT引導(dǎo)立體定向蒼白球腹后內(nèi)側(cè)部切開術(shù)治療帕金森病[J];河北醫(yī)藥;2004年02期
4 汪業(yè)漢;許建平;成良正;付先明;陳東朝;;帕金森氏病第二次對(duì)側(cè)手術(shù)腦內(nèi)有效靶點(diǎn)的選擇[J];立體定向和功能性神經(jīng)外科雜志;1993年01期
5 喻廉,凌至培,汪業(yè)漢,凌士營(yíng),姜曉峰,錢若兵,李光群,孫華明;帕金森病人GPi、Vim及STN的電生理特性研究[J];立體定向和功能性神經(jīng)外科雜志;2002年02期
6 史有才,王愛萍,楊江河;MRI定位微電極引導(dǎo)Vim核毀損術(shù)治療藥物難治性震顫[J];立體定向和功能性神經(jīng)外科雜志;2003年01期
7 趙春生,付震,耿曉增,吳幼章,余同福;電生理功能定位在蒼白球腹后部毀損術(shù)治療帕金森病中的臨床價(jià)值[J];立體定向和功能性神經(jīng)外科雜志;2003年01期
8 張樹芳,,齊達(dá)錦;腦立體定向丘腦腹外側(cè)核毀損術(shù)治療帕金森氏病17例報(bào)告[J];立體定向和功能性神經(jīng)外科雜志;1995年03期
9 祁宜志,徐德生,劉東,鄭立高;立體定向丘腦腹外側(cè)核毀損治療帕金森病[J];天津醫(yī)藥;2003年01期
10 趙亞群;周敬安;張輝;;帕金森病患者蒼白球神經(jīng)元放電特性與癥狀的關(guān)系[J];中國(guó)臨床康復(fù);2006年02期
本文編號(hào):2326872
本文鏈接:http://sikaile.net/yixuelunwen/binglixuelunwen/2326872.html